Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: shandong

    Main Sales Markets: North America,Western Europe,Eastern Europe,Australasia,Asia,Africa

  • Monthly Production Capacity: 100kg

    Packaging Information: Bag/drum

  • Delivery Lead Time: within 3 days

    Sample Provided: no

    Payment Terms: TT in advance

    Loxo-292 is one such oral, highly selective drug in development that can target tumors with mutations in the RET gene. It inhibits natural RET signaling and the expected acquired resistance mechanism, which enables the activity of the therapy.

Send your message to this supplier
  • From:
  • To:
    Jinan Jianfeng Chemical Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service